In this section
HelixTalk
In this section
This podcast is produced by pharmacy faculty to supplement study material and provide relevant drug and professional topics. We're hoping that our real-life clinical pearls and discussions will help you stay up-to-date and improve your pharmacy knowledge.
How Do I Listen?
HelixTalk is available via , by , subscribing to our mailing list, or by listening to any episode in your browser (below).
HelixTalk Episodes
HelixTalk #187 - Infectious Ambitions: A Pharmacist's Career Pivot from Clinical to Industry
Date posted: January 23, 2025, 2:47 pm
In this episode, we interview Morgan Anderson, PharmD, BCIDP, a graduate of the Â鶹ӰÒôMS College of Pharmacy, about her career path from a pharmacy resident, emergency medicine specialist, infectious diseases specialist, and now a medical sciences liaison.
The views, thoughts, and opinions expressed in this podcast are solely Dr. Anderson’s own and do not necessarily reflect the views, positions, or policies of her employer. This podcast is conducted in a personal capacity, and any reference to her professional background is for context only.
HelixTalk #186 - Breaking the Bank or Breaking the Scale: Controversies Surrounding Compounded GLP-1s RAs for Weight Loss
Date posted: December 12, 2024, 2:43 pm
In this episode, we discuss the efficacy and safety of semaglutide and tirzepatide for weight loss with a particular focus on the legal, regulatory, and safety aspects of these “compounded” GLP-1 receptor agonist medications.
HelixTalk #185 - They Are Late, but Don’t Stress: The New 2024 Stress Ulcer Prophylaxis Guidelines
Date posted: October 4, 2024, 10:34 am
In this episode, we review the recommendations from the 2024 SCCM/ASHP stress ulcer prophylaxis guidelines and highlight three of the more recent landmark critical care trials investigating the role of stress ulcer prophylaxis.
HelixTalk #184 - Drop it Like it’s Hot! Deprescribing Pharmacotherapy When Appropriate
Date posted: August 9, 2024, 4:00 pm
In this episode, we discuss the approach to deprescribing for several drugs such as benzodiazepine receptor agonists, cholinesterase inhibitors, memantine, antipsychotics, and antihyperglycemics.